Valuation: Stereotaxis Inc

Market Cap 123M 110M 102M 93.42M 175M 11.87B 178M 1.24B 479M 6.05B 463M 453M 19.48B P/E 2026 *
-6.05x
P/E 2027 * -8.39x
Enterprise Value 123M 110M 102M 93.42M 175M 11.87B 178M 1.24B 479M 6.05B 463M 453M 19.48B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 2.7x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Change 5-day change 1-year change 3-year change Capi.($)
-7.43%-2.84% - - 123M
-3.34%-1.92%+34.53%+28.91% 250B
-4.42%-4.42%+6.81%-14.65% 156B
-1.33%+0.74%-10.28%+37.27% 144B
-0.96%-3.12%-55.72%-18.12% 63.26B
-1.31%-1.88%+9.54%+22.96% 49.75B
-3.27%+0.82%+29.86%+49.06% 48.58B
-0.95%+1.10%-18.27%-21.65% 47.99B
-1.23%+4.13%-5.36%+38.57% 46.22B
-3.15%+1.18%+41.93%+55.18% 43.17B
Average -2.09%+2.27%+3.67%+19.73% 94.22B
Weighted average by Cap. -1.47%+2.37%+8.60%+18.63%

Financials

2026 *2027 *
Net sales 34.33M 30.54M 28.51M 26.02M 48.82M 3.31B 49.55M 344M 134M 1.69B 129M 126M 5.43B 45.67M 40.62M 37.91M 34.61M 64.94M 4.4B 65.91M 458M 178M 2.24B 171M 168M 7.22B
Net income -20.13M -17.91M -16.72M -15.26M -28.63M -1.94B -29.06M -202M -78.29M -988M -75.59M -73.95M -3.18B -14.77M -13.14M -12.26M -11.19M -21M -1.42B -21.31M -148M -57.42M -725M -55.44M -54.24M -2.33B
Net Debt - -
Logo Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-